| KRYS Stock | | | USD 196.91 0.39 0.20% |
Krystal Biotech financial indicator trend analysis is infinitely more than just investigating Krystal Biotech recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Krystal Biotech is a good investment. Please check the relationship between Krystal Biotech Price To Sales Ratio and its Average Payables accounts. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Krystal Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in manufacturing.
For more information on how to buy Krystal Stock please use our
How to Invest in Krystal Biotech guide.
Price To Sales Ratio vs Average Payables
Price To Sales Ratio vs Average Payables Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Krystal Biotech Price To Sales Ratio account and
Average Payables. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Krystal Biotech's Price To Sales Ratio and Average Payables is 0.43. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Average Payables in the same time period over historical financial statements of Krystal Biotech, assuming nothing else is changed. The correlation between historical values of Krystal Biotech's Price To Sales Ratio and Average Payables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of Krystal Biotech are associated (or correlated) with its Average Payables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Average Payables has no effect on the direction of Price To Sales Ratio i.e., Krystal Biotech's Price To Sales Ratio and Average Payables go up and down completely randomly.
Correlation Coefficient | 0.43 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Krystal Biotech stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Krystal Biotech sales, a figure that is much harder to manipulate than other Krystal Biotech multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.
Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.
Most indicators from Krystal Biotech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Krystal Biotech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Krystal Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in manufacturing.
For more information on how to buy Krystal Stock please use our
How to Invest in Krystal Biotech guide.At this time, Krystal Biotech's
Selling General Administrative is comparatively stable compared to the past year.
Tax Provision is likely to gain to about 2.1
M in 2024, whereas
Issuance Of Capital Stock is likely to drop slightly above 164
M in 2024.
Krystal Biotech fundamental ratios Correlations
Click cells to compare fundamentals
Krystal Biotech Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Krystal Biotech fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Krystal Stock Analysis
When running Krystal Biotech's price analysis, check to
measure Krystal Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Krystal Biotech is operating at the current time. Most of Krystal Biotech's value examination focuses on studying past and present price action to
predict the probability of Krystal Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Krystal Biotech's price. Additionally, you may evaluate how the addition of Krystal Biotech to your portfolios can decrease your overall portfolio volatility.